Aims & Scope
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments
on the medicinal chemistry, pharmacology, molecular biology, genomics and
biochemistry of contemporary molecular targets involved in neurological and
central nervous system (CNS) disorders e.g. disease specific proteins,
receptors, enzymes, genes.
CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders
in the field covering a range of current topics of CNS & neurological drug
targets. The journal also accepts for publication original research articles,
letters, reviews and drug clinical trial studies.
As the discovery, identification, characterization and
validation of novel human drug targets for neurological and CNS drug discovery
continues to grow; this journal is essential reading for all pharmaceutical
scientists involved in drug discovery and development.
